Your best medicine news resource
Feb 27th 2008Drug InformationHIV / AIDS
The practice of recruiting trained health personnel from sub-Saharan Africa to work in developed nations is weakening health infrastructures and undermining efforts to fight HIV/AIDS in the region, according to an article published in the Feb. 23 issue of the Lancet, Reuters reports.
More: continued here
Feb 27th 2008Drug InformationImmune System / Vaccines
A novel technique for vaccinating against a variety of infectious diseases using an oil-based emulsion placed in the nose, rather than needles has proved able to produce a strong immune response against smallpox and HIV in two new studies.The results build on previous success in animal studies with a nasal nanoemulsion vaccine for influenza, reported by University of Michigan researchers in 2003.
More: continued here
Feb 27th 2008Drug InformationHealth Insurance / Medical Insurance
The New Hampshire Legislature on Friday approved $50 million in cuts to the fiscal year 2008 state budget, including reductions in Medicaid hospital payments, AP/Foster’s Daily Democrat reports. Funding for the state
More: continued here
Feb 27th 2008Drug InformationCancer
The Children’s Cancer Hospital Foundation 57357 (CCHF) in Egypt announced that it has selected Cerner Corporation (NASDAQ:CERN) as the healthcare information technology (HIT) provider for Children’s Cancer Hospital Egypt 57357. The hospital will use multiple Cerner Millennium® solutions to help clinicians provide state-of-the-art care for an estimated 1,500 pediatric cancer patients each year.
More: continued here
Feb 27th 2008Drug InformationBreast Cancer
Canadian women diagnosed with early breast cancer lose, on average, more than a quarter of their typical income during the first 12 months after their diagnosis, according to a study published online in the Journal of the National Cancer Institute.Although a number of studies have assessed the economic impact of breast cancer on the healthcare system, few studies have examined the impact the disease has on the financial status of patients and their families.
More: continued here
Feb 27th 2008Drug InformationDepression
More than half of teenagers with the most debilitating forms of depression that do not respond to treatment with selective serotonin reuptake inhibitors (SSRIs) show improvement after switching to a different medication combined with cognitive behavioral therapy, researchers at UT Southwestern Medical Center and their colleagues in a multicenter study have found.Dr.
More: continued here
Feb 27th 2008Drug InformationCardiovascular
In an article published in the March issue of the Journal of Cardiovascular Pharmacology and Therapeutics, researchers from Florida Atlantic University (FAU) assess the totality of evidence, including strengths and limitations of different types of evidence contributing to the debate about cardiovascular disease (CVD) risks of cyclooxygenase-2 (COX-2) inhibitors and non-steroidal anti-inflammatory drugs (NSAIDs).
More: continued here
Feb 27th 2008Drug InformationDepression
The Royal College of Psychiatrists has urged people taking antidepressants not to discontinue their medication without consulting a doctor.NICE guidelines point to the efficacy of antidepressants as well as cognitive behaviour therapy (CBT) and interpersonal psychotherapy (IPT) for people with moderate to severe depression. Many studies have shown that a combination of medication and psychotherapy has been particularly effective.
More: continued here
Feb 27th 2008Drug InformationCardiovascular
French researchers announced a striking 15% decrease in admissions of patients with myocardial infarction to emergency wards since the public ban on smoking came into effect in restaurants, hotels and casinos in France last January. The announcement was made on 23 February by the National Sanitary Institute. Similar results were published in Italy on 12 February by the Environmental Health Authority: researchers in Rome found an 11.
More: continued here
Feb 27th 2008Drug InformationNeurology / Neuroscience
Synthetic Blood International, Inc. (OTCBB:SYBD) announced that The United States Department of Defense (DoD) has approved the award of a $1.9 million grant to M. Ross Bullock, M.D., Ph.D., of the University of Miami Miller School of Medicine, Department of Neurosurgery and principal investigator for the Company’s planned Phase IIb clinical trial with Oxycyte? for the treatment of traumatic brain injury (TBI).
More: continued here
Your best medicine news resource
